Patent Reform Bill In House Limits “Inequitable Conduct” Defense
Executive Summary
Amended patent reform legislation that cleared the House Judiciary Committee July 18 responds to innovator drug industry concerns by limiting the circumstances in which the inequitable conduct defense may be used in patent challenges
You may also be interested in...
Patent Reform: Brands Get Damages, Generics Have Inequitable Conduct
Patent reform legislation exited the Senate Judiciary Committee April 2 without apportionment of damages or inequitable conduct language, providing both brand and generic pharmaceutical companies with something to like
Patent Reform: Brands Get Damages, Generics Have Inequitable Conduct
Patent reform legislation exited the Senate Judiciary Committee April 2 without apportionment of damages or inequitable conduct language, providing both brand and generic pharmaceutical companies with something to like
Patent Reform Legislation Introduced; Damages, Inequitable Conduct In Flux
Senate language from the patent reform debate in the last Congress will be the starting point this year for negotiations on how to calculate a reasonable royalty for patent infringement